FUNCTIONING AND QUALITY OF LIFE IN PATIENTS WITH BIPOLAR DISORDER- RESULTS FROM THE MULTINATIONAL LONGITUDINAL WAVE-BD STUDY

Author(s)

Vieta E1, Figueira ML2, Bellivier F3, Souery D4, Blasco-Colmenares E5, Langosch JM6, Medina E7, Gonzalez MA81Bipolar Disorders Programme University of Barcelona, Hospital Clínic, IDIBAPS, CIBERSAM, Barcelona, Spain, 2University of Lisbon, Lisboa , Portugal, 3Hôpital Henri Mondor, Créteil cedex, France, 4Centre Européen de Psychologie Médicale, Psy-Pluriel, Brussels, Belgium, 5Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA, 6Bethanien Hospital for Psychiatry, Greifswald, Germany, 7AstraZeneca Pharmaceuticals LP, Madrid, Spain, 8Quintiles Global Consulting, Madrid, Spain

OBJECTIVES: Individuals with bipolar disorder (BD) experience a high degree of impairment that affects aspects of daily life including autonomy, relationships and employment. The Wide AmbispectiVE study of the clinical management and burden of bipolar disorder (WAVE-bd) aimed to describe functioning and quality of life (QoL) in a multinational BD cohort. METHODS: Multinational, multicenter, non-interventional, cohort study of patients diagnosed with BD-I or BD-II with ≥1 mood episode in the preceding 12 months (retrospective data collection) followed by a minimum 9 months’ prospective follow-up. Functioning was measured using the Functioning Assessment Short Test (FAST) tool (score range: 0-72, higher score indicates worse functionality, results presented from initial visit). QoL was measured with the EuroQoL-5D visual analogue scale (VAS) tool (score range: 0-100, higher score indicates better health), and the EQ-5D Index (score range: 0-1, higher score indicates better health) at every visit during the study. RESULTS: Overall, 2,896 patients were included in the analysis (1,989 BD-I, 907 BD-II).  FAST total scores (mean±SD) for BD-I and BD–II patients, respectively, were 50.1±17.2 and 48.8±16.5. QoL fluctuated with disease phase; in BD-I patients the EQ-5D VAS scores (mean±SD) were 71.9±18.3 in hypomania, 70.4±18.7 in euthymia, 69.6±22.8 in mania, 56.5±18.5 in mixed episodes, and 53.5±22.0 in depression. In BD-II patients, EQ-5D VAS scores were 72.1±18.7 in hypomania, 70.0±17.8 in euthymia and 54.2±20.2 in depression. EQ-5D Index scores (mean±SD) reflected a similar trend (BD-I: hypomania 0.70±0.28, mania 0.67±0.29, mixed episodes 0.53±0.28, depression 0.49±0.29, euthymia 0.41±0.27; BD-II: hypomania 0.65±0.27, depression 0.46±0.27, euthymia 0.41±0.26). CONCLUSIONS: Patients with BD-I and BD-II experienced a high level of functional impairment compared to healthy individuals. QoL was similar in both BD-I and BD-II, and was lowest in patients experiencing depressive and mixed episodes, and highest in hypomanic episodes and euthymia.

Conference/Value in Health Info

2012-06, ISPOR 2012, Washington, D.C., USA

Value in Health, Vol. 15, No. 4 (June 2012)

Code

PMH56

Topic

Patient-Centered Research

Topic Subcategory

Patient-reported Outcomes & Quality of Life Outcomes

Disease

Mental Health

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×